Human Cancer Associated Endothelial Cells — Save 20.00% OFF sitewide! Use Code: CAE2026 Shop Now

Human VEGFR1 shRNA Stable Transfected HUVECs

NBP-0001siRNAVEGFR1 Primary Cells
$860.00
Starting price per unit
Human VEGFR1 shRNA Stable Transfected HUVECs
In Stock 1ml
Product Type Human Endothelial cells
Viability >95% viable (Trypan Blue exclusion)
Storage Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life Very stable in the Liquid Nitrogen Vapor Phase

Quick Actions

Quality Certified
Global Shipping Available
Technical Support Included
Documentation 0 files
No documentation available for this product.

Product Overview

Description

Human VEGFR1 shRNA Stable Transfected Human Umbilical Vein Endothelial Cells (HUVECs) are genetically modified endothelial cells engineered to stably express short hairpin RNA (shRNA) targeting the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1/Flt-1) gene. This stable knockdown reduces VEGFR1 expression, allowing researchers to investigate its role in endothelial cell signaling, angiogenesis, vascular development, and disease progression.

These cells maintain the fundamental characteristics of primary HUVECs while providing a reliable in vitro model for long-term functional studies involving VEGFR1 suppression.

Guarantee expansion for a minimum of 2-5 population
doublings.

IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.

Key Features

Catalog Number: NBP-0001siRNAVEGFR1
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)

CELL CHARACTERISTICS

-Stable shRNA-mediated knockdown of VEGFR1 (Flt-1) expression.
-Human endothelial cell morphology with typical cobblestone appearance.
-Reduced VEGFR1 mRNA and protein levels.
-Altered VEGF signaling pathways and receptor interactions.
-Suitable for long-term experiments without repeated transfection.
-Retains expression of endothelial markers such as:
-CD31 (PECAM-1)
-VE-Cadherin (CD144)
-von Willebrand Factor (vWF)
-Compatible with fluorescence imaging, molecular biology, and functional assays.
-High reproducibility for angiogenesis and vascular biology research.

Quick Facts
Product Type

Human Endothelial cells

Viability

>95% viable (Trypan Blue exclusion)

Applications

-Angiogenesis Research Investigation of VEGFR1 f…

Availability

In Stock • Global Shipping

Technical Specifications

Product Type
Human Endothelial cells
Viability
>95% viable (Trypan Blue exclusion)
Proliferative Capability
Primary cells capable of multiple passages when using recommended medium and proper handling
Storage Conditions
Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life
Very stable in the Liquid Nitrogen Vapor Phase
Product Code
NBP-0001siRNAVEGFR1
Size/Format
1ml
Primary Applications
-Angiogenesis Research Investigation of VEGFR1 function in blood vessel formation. Analysis of endothelial migration proliferation and tube formation. Evaluation of VEGF-mediated signaling mechanisms. -Cancer and Tumor Biology Study of tumor-associated angiogenesis. Assessment of VEGFR1 involvement in tumor vascularization. Screening of anti-angiogenic therapeutics. -Vascular Disease Studies Research on atherosclerosis and vascular remodeling. Investigation of endothelial dysfunction. Analysis of inflammatory vascular responses. -Drug Discovery and Development Validation of VEGFR1-targeted therapies. Screening of small molecules antibodies and biologics. Evaluation of pathway-specific therapeutic interventions. -Molecular Signaling Studies Investigation of VEGF/VEGFR signaling networks. Examination of receptor cross-talk between VEGFR1 and VEGFR2. Analysis of downstream signaling pathways including PI3K/Akt and MAPK.

Applications & Use Cases

Primary Applications
-Angiogenesis Research Investigation of VEGFR1 function in blood vessel formation. Analysis of endothelial migration

Suitable for -angiogenesis research investigation of vegfr1 function in blood vessel formation. analysis of endothelial migration studies and research applications

proliferation

Suitable for proliferation studies and research applications

and tube formation. Evaluation of VEGF-mediated signaling mechanisms. -Cancer and Tumor Biology Study of tumor-associated angiogenesis. Assessment of VEGFR1 involvement in tumor vascularization. Screening of anti-angiogenic therapeutics. -Vascular Disease Studies Research on atherosclerosis and vascular remodeling. Investigation of endothelial dysfunction. Analysis of inflammatory vascular responses. -Drug Discovery and Development Validation of VEGFR1-targeted therapies. Screening of small molecules

Suitable for and tube formation. evaluation of vegf-mediated signaling mechanisms. -cancer and tumor biology study of tumor-associated angiogenesis. assessment of vegfr1 involvement in tumor vascularization. screening of anti-angiogenic therapeutics. -vascular disease studies research on atherosclerosis and vascular remodeling. investigation of endothelial dysfunction. analysis of inflammatory vascular responses. -drug discovery and development validation of vegfr1-targeted therapies. screening of small molecules studies and research applications

antibodies

Suitable for antibodies studies and research applications

and biologics. Evaluation of pathway-specific therapeutic interventions. -Molecular Signaling Studies Investigation of VEGF/VEGFR signaling networks. Examination of receptor cross-talk between VEGFR1 and VEGFR2. Analysis of downstream signaling pathways including PI3K/Akt and MAPK.

Suitable for and biologics. evaluation of pathway-specific therapeutic interventions. -molecular signaling studies investigation of vegf/vegfr signaling networks. examination of receptor cross-talk between vegfr1 and vegfr2. analysis of downstream signaling pathways including pi3k/akt and mapk. studies and research applications

Research Areas
In Vitro Studies

Cell culture and screening applications

Molecular Biology

Gene expression & signaling studies

Drug Discovery

Screening & validation studies

Disease Modeling

Pathophysiology research

Support & Resources

Technical Support

Our experts are available for technical questions and protocol assistance.

Contact Support
Documentation

Access product datasheets, protocols, and certificates.

Request Documentation
Shipping & Logistics

Temperature-controlled shipping to 40+ countries worldwide.

Shipping Info
FAQ & Resources

Find answers to common questions and optimization tips.

View FAQs

Our Worldwide Locations

Find a distributor near you

MoreBio

MoreBio

Advancing Life Science, Globally

Address F810, Testa Tower, 25, Misagangbyeonseo-ro
Hanam-si, Gyeonggi-do, Republic of Korea, 12918
Korea
Contact yhwoo@morebio.co.kr
+82-2-406-2942
+82-31-735-2944